M&A Deal Summary

Trinity Biotech Acquires EpiCapture

On October 25, 2024, Trinity Biotech acquired life science company EpiCapture for 3M USD

Acquisition Highlights
  • This is Trinity Biotech’s 4th transaction in the Life Science sector.
  • This is Trinity Biotech’s 4th largest (disclosed) transaction.
  • This is Trinity Biotech’s 3rd transaction in Ireland.

M&A Deal Summary
Date 2024-10-25
Target EpiCapture
Sector Life Science
Buyer(s) Trinity Biotech
Deal Type Add-on Acquisition
Deal Value 3M USD

Target

EpiCapture

Dublin, Ireland
EpiCapture is a company developing a non-invasive test for monitoring the risk of aggressive prostate cancer. EpiCapture is based in Dublin, Ireland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Trinity Biotech

Bray, Ireland
Category Company
Founded 1992
Sector Healthcare Services
Employees380
Revenue 57M USD (2023)
DESCRIPTION

Trinity Biotech is an entity acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. Trinity Biotech was founded in 1992 and is based in Bray, Ireland.

DEAL STATS #
Overall 9 of 9
Sector (Life Science) 4 of 4
Type (Add-on Acquisition) 6 of 6
Country (Ireland) 3 of 3
Year (2024) 4 of 4
Size (of disclosed) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-24 Metabolomic Diagnostics

Co. Cork, Ireland

Metabolomic Diagnostics is an Irish deep-tech company, specializing in the development of novel biomarker-based diagnostic solutions for complex diseases. Metabolomic Diagnostics is based in Co. Cork, Ireland.

Buy -
Mergr

Product

Company

Legal